Journal Report

Expert Review of Anticancer Therapy

Download PDF
Journal Information
Journal Title
Expert Review of Anticancer Therapy
Publisher
Taylor and Francis Ltd.
ISSN
1473-7140
E-ISSN
1744-8328
Database
SCOPUS
Domain
Health Sciences, Life Sciences
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023 ✓ ✓
2021/2022 ✓ ✓
2020 ✓ ✓
2019 ✓ ✓
2018 ✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Trastuzumab deruxtecan in HER2-expressing urothelial carcinoma: current evidence, biomarker challenges, and future therapeutic strategies
Giandomenico Roviello, Kristian Shtembari, Ismaela Anna Vascotto et al.
2026-11-5 Pages 1-10
DOI: 10.1080/14737140.2026.2760188
Biological state–guided oncology: a framework for dynamic precision cancer care through oncological state transitions
Takehiro Okabayashi, Ryo Inada, Motoyasu Tabuchi et al.
2026-11-5
DOI: 10.1080/14737140.2026.2760189
TROP2-directed antibody-drug conjugates (ADCs) challenge of predicting clinical outcome
Laura Stanbery, Daniel Craig, Lauren Rager et al.
2026-11-4 Pages 1-13
DOI: 10.1080/14737140.2026.2756200
Survivorship in gynecological cancers: addressing psychosocial and physical challenges
Hadley W. Reid, Brittany A. Davidson
2026-11-3 Pages 1-13
DOI: 10.1080/14737140.2026.2758536
Uveal melanoma: innovations in therapy, prognosis, and imaging
Nikhith Rao, Shrihari Nagarajan, Lauren A. Dalvin
2026-10-29 Pages 1-19
DOI: 10.1080/14737140.2026.2755251
Myelodysplastic syndromes/neoplasms presenting with isolated thrombocytopenia: a poorly understood pathophysiology, difficult to diagnose, and challenging to treat entity
Shehab F. Mohamed, Mohammed Abdulgayoom, Abdulrahman F. Al-Mashdali et al.
2026-10-29 Pages 1-19
DOI: 10.1080/14737140.2026.2746616
Apalutamide in prostate cancer: clinical evidence, disease modification hypothesis, and emerging treatment de‑intensification strategies
Martina Catalano, Giandomenico Roviello
2026-10-15 Pages 1-8
DOI: 10.1080/14737140.2026.2749345
Targeting <i>KIT</i> and <i>PDGFRA</i> mutations in advanced GIST: current and future clinical implications
Alice Costa, Annalisa Astolfi, Livia Gozzellino et al.
2026-10-11 Pages 1-11
DOI: 10.1080/14737140.2026.2746618
How zongertinib was developed for HER2-mutant non-small cell lung cancer: a plain language summary
John V Heymach, Birgit Wilding
2026-10-11 Pages 1-8
DOI: 10.1080/14737140.2026.2731196
Real-world clinical and economic outcomes in chemotherapy-naïve patients with metastatic castration-resistant prostate cancer
Rana R. McKay, Jennifer Nguyen, Barinder Kang et al.
2026-10-6 Pages 1-11
DOI: 10.1080/14737140.2026.2738626
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: November 7, 2026 18:06